0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global NK Cell Therapy Market Size, Status and Forecast 2021-2027
Published Date: June 2021
|
Report Code: QYRE-Othe-085
Home | Market Reports | Health
Global NK Cell Therapy Market Size Status and Forecast 2021 2027

Global NK Cell Therapy Market Size, Status and Forecast 2021-2027

Code: QYRE-Othe-085
Report
June 2021
105 Pages
QYResearch
Region: Asia Pacific, North America, Europe, Global,
Description
Table of Content
Tables & Figures

The global NK Cell Therapy market size is projected to reach US$ 856.3 million by 2027, from US$ 299.3 million in 2020, at a CAGR of 16.2% during 2021-2027.

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
 
The North America natural killer cells therapeutics market share accounted for the highest share 52.4% in 2018 and is expected to continue its dominance throughout the forecast period. This is attributed to significant increase in prevalence of cancer in this region. However, the Asia market is anticipated to grow at the fastest pace, owing to increase in number of patients suffering from cancer, surge in geriatric population, and improvement in healthcare facilities. However, the complexity in regulatory frameworks regarding the approval of immunotherapy is expected to hamper the market growth.
 
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global NK Cell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global NK Cell Therapy market
in terms of revenue.
 
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global NK Cell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global NK Cell Therapy market.
 
NK Cell Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global NK Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
 

Segment by Type

  • NK Cell Therapies
  • NK Cell Directed Antibodies
  • NK Cell agents took the largest market share segment, accounting for 82% and growing fastest 

Segment by Application

  • Cancer
  • Gastrointestinal Diseases
  • Others
  • Cancer was the most widely used area at 66% 

BY REGION

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Russia
  • Nordic
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

BY COMPANY

  • Nektar Therapeutics
  • Innate Pharma SA
  • Affimed
  • Chipscreen Biosciences
  • Fate Therapeutics
  • Glycostem Therapeutics
  • Dragonfly Therapeutics
  • Kiadis Pharma
  • NantWorks
  • Nkarta Therapeutics
  • Fortress Biotech
 
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NK Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 NK Cell Therapies
1.2.3 NK Cell Directed Antibodies
1.3 Market by Application
1.3.1 Global NK Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Gastrointestinal Diseases
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global NK Cell Therapy Market Perspective (2016-2027)
2.2 NK Cell Therapy Growth Trends by Regions
2.2.1 NK Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 NK Cell Therapy Historic Market Share by Regions (2016-2021)
2.2.3 NK Cell Therapy Forecasted Market Size by Regions (2022-2027)
2.3 NK Cell Therapy Industry Dynamic
2.3.1 NK Cell Therapy Market Trends
2.3.2 NK Cell Therapy Market Drivers
2.3.3 NK Cell Therapy Market Challenges
2.3.4 NK Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NK Cell Therapy Players by Revenue
3.1.1 Global Top NK Cell Therapy Players by Revenue (2016-2021)
3.1.2 Global NK Cell Therapy Revenue Market Share by Players (2016-2021)
3.2 Global NK Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by NK Cell Therapy Revenue
3.4 Global NK Cell Therapy Market Concentration Ratio
3.4.1 Global NK Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NK Cell Therapy Revenue in 2020
3.5 NK Cell Therapy Key Players Head office and Area Served
3.6 Key Players NK Cell Therapy Product Solution and Service
3.7 Date of Enter into NK Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NK Cell Therapy Breakdown Data by Type
4.1 Global NK Cell Therapy Historic Market Size by Type (2016-2021)
4.2 Global NK Cell Therapy Forecasted Market Size by Type (2022-2027)
5 NK Cell Therapy Breakdown Data by Application
5.1 Global NK Cell Therapy Historic Market Size by Application (2016-2021)
5.2 Global NK Cell Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America NK Cell Therapy Market Size (2016-2027)
6.2 North America NK Cell Therapy Market Size by Type
6.2.1 North America NK Cell Therapy Market Size by Type (2016-2021)
6.2.2 North America NK Cell Therapy Market Size by Type (2022-2027)
6.2.3 North America NK Cell Therapy Market Size by Type (2016-2027)
6.3 North America NK Cell Therapy Market Size by Application
6.3.1 North America NK Cell Therapy Market Size by Application (2016-2021)
6.3.2 North America NK Cell Therapy Market Size by Application (2022-2027)
6.3.3 North America NK Cell Therapy Market Size by Application (2016-2027)
6.4 North America NK Cell Therapy Market Size by Country
6.4.1 North America NK Cell Therapy Market Size by Country (2016-2021)
6.4.2 North America NK Cell Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe NK Cell Therapy Market Size (2016-2027)
7.2 Europe NK Cell Therapy Market Size by Type
7.2.1 Europe NK Cell Therapy Market Size by Type (2016-2021)
7.2.2 Europe NK Cell Therapy Market Size by Type (2022-2027)
7.2.3 Europe NK Cell Therapy Market Size by Type (2016-2027)
7.3 Europe NK Cell Therapy Market Size by Application
7.3.1 Europe NK Cell Therapy Market Size by Application (2016-2021)
7.3.2 Europe NK Cell Therapy Market Size by Application (2022-2027)
7.3.3 Europe NK Cell Therapy Market Size by Application (2016-2027)
7.4 Europe NK Cell Therapy Market Size by Country
7.4.1 Europe NK Cell Therapy Market Size by Country (2016-2021)
7.4.2 Europe NK Cell Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific NK Cell Therapy Market Size (2016-2027)
8.2 Asia-Pacific NK Cell Therapy Market Size by Type
8.2.1 Asia-Pacific NK Cell Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific NK Cell Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific NK Cell Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific NK Cell Therapy Market Size by Application
8.3.1 Asia-Pacific NK Cell Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific NK Cell Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific NK Cell Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific NK Cell Therapy Market Size by Region
8.4.1 Asia-Pacific NK Cell Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific NK Cell Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America NK Cell Therapy Market Size (2016-2027)
9.2 Latin America NK Cell Therapy Market Size by Type
9.2.1 Latin America NK Cell Therapy Market Size by Type (2016-2021)
9.2.2 Latin America NK Cell Therapy Market Size by Type (2022-2027)
9.2.3 Latin America NK Cell Therapy Market Size by Type (2016-2027)
9.3 Latin America NK Cell Therapy Market Size by Application
9.3.1 Latin America NK Cell Therapy Market Size by Application (2016-2021)
9.3.2 Latin America NK Cell Therapy Market Size by Application (2022-2027)
9.3.3 Latin America NK Cell Therapy Market Size by Application (2016-2027)
9.4 Latin America NK Cell Therapy Market Size by Country
9.4.1 Latin America NK Cell Therapy Market Size by Country (2016-2021)
9.4.2 Latin America NK Cell Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NK Cell Therapy Market Size (2016-2027)
10.2 Middle East & Africa NK Cell Therapy Market Size by Type
10.2.1 Middle East & Africa NK Cell Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa NK Cell Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa NK Cell Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa NK Cell Therapy Market Size by Application
10.3.1 Middle East & Africa NK Cell Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa NK Cell Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa NK Cell Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa NK Cell Therapy Market Size by Country
10.4.1 Middle East & Africa NK Cell Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa NK Cell Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Nektar Therapeutics
11.1.1 Nektar Therapeutics Company Details
11.1.2 Nektar Therapeutics Business Overview
11.1.3 Nektar Therapeutics NK Cell Therapy Introduction
11.1.4 Nektar Therapeutics Revenue in NK Cell Therapy Business (2016-2021)
11.1.5 Nektar Therapeutics Recent Development
11.2 Innate Pharma SA
11.2.1 Innate Pharma SA Company Details
11.2.2 Innate Pharma SA Business Overview
11.2.3 Innate Pharma SA NK Cell Therapy Introduction
11.2.4 Innate Pharma SA Revenue in NK Cell Therapy Business (2016-2021)
11.2.5 Innate Pharma SA Recent Development
11.3 Affimed
11.3.1 Affimed Company Details
11.3.2 Affimed Business Overview
11.3.3 Affimed NK Cell Therapy Introduction
11.3.4 Affimed Revenue in NK Cell Therapy Business (2016-2021)
11.3.5 Affimed Recent Development
11.4 Chipscreen Biosciences
11.4.1 Chipscreen Biosciences Company Details
11.4.2 Chipscreen Biosciences Business Overview
11.4.3 Chipscreen Biosciences NK Cell Therapy Introduction
11.4.4 Chipscreen Biosciences Revenue in NK Cell Therapy Business (2016-2021)
11.4.5 Chipscreen Biosciences Recent Development
11.5 Fate Therapeutics
11.5.1 Fate Therapeutics Company Details
11.5.2 Fate Therapeutics Business Overview
11.5.3 Fate Therapeutics NK Cell Therapy Introduction
11.5.4 Fate Therapeutics Revenue in NK Cell Therapy Business (2016-2021)
11.5.5 Fate Therapeutics Recent Development
11.6 Glycostem Therapeutics
11.6.1 Glycostem Therapeutics Company Details
11.6.2 Glycostem Therapeutics Business Overview
11.6.3 Glycostem Therapeutics NK Cell Therapy Introduction
11.6.4 Glycostem Therapeutics Revenue in NK Cell Therapy Business (2016-2021)
11.6.5 Glycostem Therapeutics Recent Development
11.7 Dragonfly Therapeutics
11.7.1 Dragonfly Therapeutics Company Details
11.7.2 Dragonfly Therapeutics Business Overview
11.7.3 Dragonfly Therapeutics NK Cell Therapy Introduction
11.7.4 Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2016-2021)
11.7.5 Dragonfly Therapeutics Recent Development
11.8 Kiadis Pharma
11.8.1 Kiadis Pharma Company Details
11.8.2 Kiadis Pharma Business Overview
11.8.3 Kiadis Pharma NK Cell Therapy Introduction
11.8.4 Kiadis Pharma Revenue in NK Cell Therapy Business (2016-2021)
11.8.5 Kiadis Pharma Recent Development
11.9 NantWorks
11.9.1 NantWorks Company Details
11.9.2 NantWorks Business Overview
11.9.3 NantWorks NK Cell Therapy Introduction
11.9.4 NantWorks Revenue in NK Cell Therapy Business (2016-2021)
11.9.5 NantWorks Recent Development
11.10 Nkarta Therapeutics
11.10.1 Nkarta Therapeutics Company Details
11.10.2 Nkarta Therapeutics Business Overview
11.10.3 Nkarta Therapeutics NK Cell Therapy Introduction
11.10.4 Nkarta Therapeutics Revenue in NK Cell Therapy Business (2016-2021)
11.10.5 Nkarta Therapeutics Recent Development
11.11 Fortress Biotech
11.11.1 Fortress Biotech Company Details
11.11.2 Fortress Biotech Business Overview
11.11.3 Fortress Biotech NK Cell Therapy Introduction
11.11.4 Fortress Biotech Revenue in NK Cell Therapy Business (2016-2021)
11.11.5 Fortress Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global NK Cell Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of NK Cell Therapies
    Table 3. Key Players of NK Cell Directed Antibodies
    Table 4. Global NK Cell Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global NK Cell Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global NK Cell Therapy Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global NK Cell Therapy Market Share by Regions (2016-2021)
    Table 8. Global NK Cell Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global NK Cell Therapy Market Share by Regions (2022-2027)
    Table 10. NK Cell Therapy Market Trends
    Table 11. NK Cell Therapy Market Drivers
    Table 12. NK Cell Therapy Market Challenges
    Table 13. NK Cell Therapy Market Restraints
    Table 14. Global NK Cell Therapy Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global NK Cell Therapy Market Share by Players (2016-2021)
    Table 16. Global Top NK Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NK Cell Therapy as of 2020)
    Table 17. Ranking of Global Top NK Cell Therapy Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by NK Cell Therapy Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players NK Cell Therapy Product Solution and Service
    Table 21. Date of Enter into NK Cell Therapy Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global NK Cell Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global NK Cell Therapy Revenue Market Share by Type (2016-2021)
    Table 25. Global NK Cell Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global NK Cell Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global NK Cell Therapy Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global NK Cell Therapy Revenue Market Share by Application (2016-2021)
    Table 29. Global NK Cell Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global NK Cell Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America NK Cell Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America NK Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America NK Cell Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America NK Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America NK Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
    Table 36. North America NK Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
    Table 37. Europe NK Cell Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe NK Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe NK Cell Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe NK Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe NK Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
    Table 42. Europe NK Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
    Table 43. Asia-Pacific NK Cell Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific NK Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific NK Cell Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific NK Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific NK Cell Therapy Market Size by Region (2016-2021) & (US$ Million)
    Table 48. Asia-Pacific NK Cell Therapy Market Size by Region (2022-2027) & (US$ Million)
    Table 49. Latin America NK Cell Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America NK Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America NK Cell Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America NK Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America NK Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
    Table 54. Latin America NK Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
    Table 55. Middle East & Africa NK Cell Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa NK Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa NK Cell Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa NK Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa NK Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
    Table 60. Middle East & Africa NK Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
    Table 61. Nektar Therapeutics Company Details
    Table 62. Nektar Therapeutics Business Overview
    Table 63. Nektar Therapeutics NK Cell Therapy Product
    Table 64. Nektar Therapeutics Revenue in NK Cell Therapy Business (2016-2021) & (US$ Million)
    Table 65. Nektar Therapeutics Recent Development
    Table 66. Innate Pharma SA Company Details
    Table 67. Innate Pharma SA Business Overview
    Table 68. Innate Pharma SA NK Cell Therapy Product
    Table 69. Innate Pharma SA Revenue in NK Cell Therapy Business (2016-2021) & (US$ Million)
    Table 70. Innate Pharma SA Recent Development
    Table 71. Affimed Company Details
    Table 72. Affimed Business Overview
    Table 73. Affimed NK Cell Therapy Product
    Table 74. Affimed Revenue in NK Cell Therapy Business (2016-2021) & (US$ Million)
    Table 75. Affimed Recent Development
    Table 76. Chipscreen Biosciences Company Details
    Table 77. Chipscreen Biosciences Business Overview
    Table 78. Chipscreen Biosciences NK Cell Therapy Product
    Table 79. Chipscreen Biosciences Revenue in NK Cell Therapy Business (2016-2021) & (US$ Million)
    Table 80. Chipscreen Biosciences Recent Development
    Table 81. Fate Therapeutics Company Details
    Table 82. Fate Therapeutics Business Overview
    Table 83. Fate Therapeutics NK Cell Therapy Product
    Table 84. Fate Therapeutics Revenue in NK Cell Therapy Business (2016-2021) & (US$ Million)
    Table 85. Fate Therapeutics Recent Development
    Table 86. Glycostem Therapeutics Company Details
    Table 87. Glycostem Therapeutics Business Overview
    Table 88. Glycostem Therapeutics NK Cell Therapy Product
    Table 89. Glycostem Therapeutics Revenue in NK Cell Therapy Business (2016-2021) & (US$ Million)
    Table 90. Glycostem Therapeutics Recent Development
    Table 91. Dragonfly Therapeutics Company Details
    Table 92. Dragonfly Therapeutics Business Overview
    Table 93. Dragonfly Therapeutics NK Cell Therapy Product
    Table 94. Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2016-2021) & (US$ Million)
    Table 95. Dragonfly Therapeutics Recent Development
    Table 96. Kiadis Pharma Company Details
    Table 97. Kiadis Pharma Business Overview
    Table 98. Kiadis Pharma Revenue in NK Cell Therapy Business (2016-2021) & (US$ Million)
    Table 99. Kiadis Pharma Recent Development
    Table 100. NantWorks Company Details
    Table 101. NantWorks Business Overview
    Table 102. NantWorks NK Cell Therapy Product
    Table 103. NantWorks Revenue in NK Cell Therapy Business (2016-2021) & (US$ Million)
    Table 104. NantWorks Recent Development
    Table 105. Nkarta Therapeutics Company Details
    Table 106. Nkarta Therapeutics Business Overview
    Table 107. Nkarta Therapeutics NK Cell Therapy Product
    Table 108. Nkarta Therapeutics Revenue in NK Cell Therapy Business (2016-2021) & (US$ Million)
    Table 109. Nkarta Therapeutics Recent Development
    Table 110. Fortress Biotech Company Details
    Table 111. Fortress Biotech Business Overview
    Table 112. Fortress Biotech NK Cell Therapy Product
    Table 113. Fortress Biotech Revenue in NK Cell Therapy Business (2016-2021) & (US$ Million)
    Table 114. Fortress Biotech Recent Development
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global NK Cell Therapy Market Share by Type: 2020 VS 2027
    Figure 2. NK Cell Therapies Features
    Figure 3. NK Cell Directed Antibodies Features
    Figure 4. Global NK Cell Therapy Market Share by Application: 2020 VS 2027
    Figure 5. Cancer Case Studies
    Figure 6. Gastrointestinal Diseases Case Studies
    Figure 7. Others Case Studies
    Figure 8. NK Cell Therapy Report Years Considered
    Figure 9. Global NK Cell Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global NK Cell Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global NK Cell Therapy Market Share by Regions: 2020 VS 2027
    Figure 12. Global NK Cell Therapy Market Share by Regions (2022-2027)
    Figure 13. Global NK Cell Therapy Market Share by Players in 2020
    Figure 14. Global Top NK Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NK Cell Therapy as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by NK Cell Therapy Revenue in 2020
    Figure 16. Global NK Cell Therapy Revenue Market Share by Type (2016-2021)
    Figure 17. Global NK Cell Therapy Revenue Market Share by Type (2022-2027)
    Figure 18. North America NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America NK Cell Therapy Market Share by Type (2016-2027)
    Figure 20. North America NK Cell Therapy Market Share by Application (2016-2027)
    Figure 21. North America NK Cell Therapy Market Share by Country (2016-2027)
    Figure 22. United States NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe NK Cell Therapy Market Share by Type (2016-2027)
    Figure 26. Europe NK Cell Therapy Market Share by Application (2016-2027)
    Figure 27. Europe NK Cell Therapy Market Share by Country (2016-2027)
    Figure 28. Germany NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific NK Cell Therapy Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific NK Cell Therapy Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific NK Cell Therapy Market Share by Region (2016-2027)
    Figure 38. China NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America NK Cell Therapy Market Share by Type (2016-2027)
    Figure 46. Latin America NK Cell Therapy Market Share by Application (2016-2027)
    Figure 47. Latin America NK Cell Therapy Market Share by Country (2016-2027)
    Figure 48. Mexico NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa NK Cell Therapy Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa NK Cell Therapy Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa NK Cell Therapy Market Share by Country (2016-2027)
    Figure 54. Turkey NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE NK Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Nektar Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2016-2021)
    Figure 58. Innate Pharma SA Revenue Growth Rate in NK Cell Therapy Business (2016-2021)
    Figure 59. Affimed Revenue Growth Rate in NK Cell Therapy Business (2016-2021)
    Figure 60. Chipscreen Biosciences Revenue Growth Rate in NK Cell Therapy Business (2016-2021)
    Figure 61. Fate Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2016-2021)
    Figure 62. Glycostem Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2016-2021)
    Figure 63. Dragonfly Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2016-2021)
    Figure 64. Kiadis Pharma Revenue Growth Rate in NK Cell Therapy Business (2016-2021)
    Figure 65. NantWorks Revenue Growth Rate in NK Cell Therapy Business (2016-2021)
    Figure 66. Nkarta Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2016-2021)
    Figure 67. Fortress Biotech Revenue Growth Rate in NK Cell Therapy Business (2016-2021)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$5850
This license allows multiple user to access the PDF.

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SIS Group of Schools

RELATED REPORTS

China Diclofenac Sodium and Codeine Phosphate Tablets Market Report Forecast 2021 2027
China Diclofenac Sodium and Codeine Phosphate Tablets Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-23N6694
Tue Oct 26 00:00:00 UTC 2021

Add to Cart

Global and Japan Plastic Bandages Market Insights Forecast to 2027
Global and Japan Plastic Bandages Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-7N7087
Tue Oct 26 00:00:00 UTC 2021

Add to Cart

China Equine Pharmaceuticals and Supplements Market Report Forecast 2021 2027
China Equine Pharmaceuticals and Supplements Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-34V6752
Tue Oct 26 00:00:00 UTC 2021

Add to Cart

Global and United States Medical Diagnostic Ultrasonic Equipment Market Insights Forecast to 2027
Global and United States Medical Diagnostic Ultrasonic Equipment Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-29X6747
Mon Oct 25 00:00:00 UTC 2021

Add to Cart